National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings, 14573 [E9-6929]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 60 / Tuesday, March 31, 2009 / Notices
tjames on PRODPC61 with NOTICES
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Medication Discovery Using Rat Models of
Relapse.
Date: April 14, 2009.
Time: 9 a.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Use of
I/M Cross-Section and m/z as a Unique
Identifier of Lipids and Neuropeptides in
Complex Biosamples.
Date: April 15, 2009.
Time: 9 a.m. to 12 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
National Hispanic Science Network.
Date: April 16, 2009.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Minna Liang, PhD,
Scientific Review Officer, Training and
Special Projects Review Branch, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, 6101 Executive Blvd.,
Room 220, MSC 8401, Bethesda, MD 20852,
301–435–1432, liangm@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Educational Marketing.
Date: April 28, 2009.
Time: 9:30 a.m. to 12 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
VerDate Nov<24>2008
14:35 Mar 30, 2009
Jkt 217001
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Long
Acting Bup for Opiate Maintenance.
Date: April 29, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Scott Chen, PhD, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, National
Institutes of Health, DHHS, 6101 Executive
Boulevard, Room 220, MSC 8401, Bethesda,
MD 20892, 301–443–9511,
chensc@mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Novel
Azetidine CB1 Antagonists.
Date: May 6, 2009.
Time: 9:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: March 20, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–6787 Filed 3–30–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
14573
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; Rheumatic
Disease Clinical Research Grant Review.
Date: March 31, 2009.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Kan Ma, PhD, Scientific
Review Officer, NIH/NIAMS, EP Review
Branch, One Democracy Plaza Suite 800,
Bethesda, MD 20892–4872, 301–594–4952,
mak2@mail.nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; Research
Project (R01) and Clinical Trial Planning
(R34) Grant Review.
Date: April 15, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Eric H. Brown, PhD,
Scientific Review Administrator, National
Institute of Arthritis and Musculoskeletal,
and Skin Diseases, 6701 Democracy Blvd,
Suite 824, Bethesda, MD 20892, (301) 594–
4955, browneri@mail.nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; Loan
Repayment Program Review.
Date: April 30, 2009.
Time: 10 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Kan Ma, PhD, Scientific
Review Officer, MH/NIAMS EP Review
Branch, One Democracy Plaza Suite 800,
Bethesda, MD 20892–4872, 301–594–4952,
mak2@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: March 23, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–6929 Filed 3–30–09; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\31MRN1.SGM
31MRN1
]]>Agencies
[Federal Register Volume 74, Number 60 (Tuesday, March 31, 2009)]
[Notices]
[Page 14573]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-6929]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel; Rheumatic
Disease Clinical Research Grant Review.
Date: March 31, 2009.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Kan Ma, PhD, Scientific Review Officer, NIH/
NIAMS, EP Review Branch, One Democracy Plaza Suite 800, Bethesda, MD
20892-4872, 301-594-4952, mak2@mail.nih.gov.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel; Research
Project (R01) and Clinical Trial Planning (R34) Grant Review.
Date: April 15, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Eric H. Brown, PhD, Scientific Review
Administrator, National Institute of Arthritis and Musculoskeletal,
and Skin Diseases, 6701 Democracy Blvd, Suite 824, Bethesda, MD
20892, (301) 594-4955, browneri@mail.nih.gov.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel; Loan
Repayment Program Review.
Date: April 30, 2009.
Time: 10 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Kan Ma, PhD, Scientific Review Officer, MH/NIAMS
EP Review Branch, One Democracy Plaza Suite 800, Bethesda, MD 20892-
4872, 301-594-4952, mak2@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: March 23, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-6929 Filed 3-30-09; 8:45 am]
BILLING CODE 4140-01-M
